{"disease":{"id":"neuroendocrine-carcinoma-carcinoid","name":"neuroendocrine carcinoma carcinoid"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03583528","title":"DOTATOC PET/CT for Imaging NET Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT03623984","title":"Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers","phase":"EARLY_PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}